Settings Today

A $4 Billion Cash Payment Lifts This Small-Cap Biotech

Ventyx Biosciences jumped 20% after Takeda handed a competitor $4 billion in cash for rights to a drug candidate still in clinical trials.

Published 869 days ago

Go Back to Reading NewsBack Read News Collect this News Article

Login to Continue, We will bring you back to this content 0



For peering opportunity Autonomouse System Number: AS401345 Custom Software Development at ErnesTech Email Address[email protected]